Dumbbell-shaped primary CNS lymphoma involving the hypothalamus and pituitary gland

Open access

Abstract

Background: Primary central nervous system lymphoma (PCNSL) involving the hypothalamus and pituitary gland is extremely rare. Therefore, no case to our knowledge has been reported to date.

Objective: We described our findings in a 48-year-old immunocompetent man, who presented with four months progressive diabetes insipidus (DI) and two months subsequent headache.

Methods and Results: A radiological study and magnetic resonance imaging (MRI) suggested a homogeneous enhancing dumbbell-shaped lesion, 2.4⃞1.2 cm in size, involving both the hypothalamus and pituitary gland. A brain biopsy was conducted through a transnasal transsphenoidal approach, and a final histopathological diagnosis of the tumor was confirmed as diffuse large B-cell malignant lymphoma. After extensive tumor surveys, including computed tomography, MRI, ultrasound, bone marrow biopsy, lumbar puncture, and positron emission tomography (PET), no evidence of other lesions found. Subsequently, he received six cycles of intravenous highdose methotrexate-based chemotherapy followed by one cycle of whole-brain radiotherapy. The progressive DI and headache completely resolved and he was in good health 11 months later.

Conclusion: Clinicians should consider the possibility of PCNSL in non specific clinical presentations.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Batchelor T Loeffler JS. Primary CNS lymphoma. J Clin Oncol. 2006; 24:1281-8.

  • 2. Eby NL Grufferman S Flannelly CM Schold SC Jr Vogel FS Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer. 1988; 62:2461-5.

  • 3. Fine HA Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993; 119:1093-104.

  • 4. Freda PU Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999; 28: 81-117.

  • 5. Gavrilovic IT Hormigo A Yahalom J DeAngelis LM Abrey LE. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006; 24:4570-4.

  • 6. Herrlinger U Schabet M Bitzer M Petersen D Krauseneck P. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol. 1999; 43:219-26.

  • 7. Huang YY Lin SF Dunn P Wai YY Hsueh C Tsai JS. Primary pituitary lymphoma presenting as hypophysitis. Endocr. J. 2005; 52:543-9.

  • 8. Kim JH Kang JK Lee SA. Hydrocephalus and hyponatremia as the presenting manifestations of primary CNS lymphoma. Eur. Neurol. 2006; 55:39-41.

  • 9. Komninos J Vlassopoulou V Protopapa D Korfias S Kontogeorgos G Sakas DE Thalassinos NC. Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab. 2004; 89: 574-80.

  • 10. Landman RE Wardlaw SL McConnell RJ Khandji AG Bruce JN Freda PU. Pituitary lymphoma presenting as fever of unknown origin. J Clin Endocrinol Metab. 2001; 86:1470-6.

  • 11. Layden BT Dubner S Toft DJ Kopp P Grimm S Molitch ME. Primary CNS lymphoma with bilateral symmetric hypothalamic lesions presenting with panhypopituitarism and diabetes insipidus. Pituitary. 2011; 14:194-7.

  • 12. Quintero WS Hood B Barker J Benveniste RJ. Primary central nervous system lymphoma mimicking pituitary apoplexy: case report. Pituitary. 2009; 12: 76-9.

  • 13. Rupp D Molitch M. Pituitary stalk lesions. Curr Opin Endocrinol Diabetes Obes. 2008; 15:339-45.

Search
Journal information
Impact Factor
IMPACT FACTOR 2018: 0.2
5-year IMPACT FACTOR: 0.293

CiteScore 2018: 0.30

SCImago Journal Rank (SJR) 2018: 0.172
Source Normalized Impact per Paper (SNIP) 2018: 0.237

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 108 56 1
PDF Downloads 39 22 0